After moving into Walter Reed National Military Medical Center late Friday, US President Donald Trump is said to spend the next few days in the hospital as a precautionary measure, White House Press Secretary Kayleigh McEnany said in a statement on Saturday.
McEnany said Trump’s symptoms are mild and that he would continue to work from a special suite at the military hospital in Maryland.
“We’re just trying to make sure that he takes it easy but he’s hard at work and will continue to,” McEnany told Fox News.
Meanwhile, Trump’s election campaign manager Bill Stepien also tested positive for COVID-19.
Calming fears over the uncertain US political climate, especially with just 31 days to for the Presidential election, White House spokesman Judd Deere said, “there will be no transfer of power from Trump to Vice President Mike Pence while the President is in the hospital.”
White House doctor Sean Conley said late on Friday that Trump was doing very well, did not need supplemental oxygen, and had received the first dose of Remdesivir, an intravenous antiviral drug sold by Gilead Sciences Inc, per Reuters.
In a tweet, early Friday, President Trump announced that he and the first lady Melania were diagnosed with COVID-19.
The anxiety over Trump’s virus contraction translated into a risk-off action in the global markets, as investors shrugged-off the optimism over a likely US fiscal stimulus deal.
Further developments concerning Trump’s health condition will be closely eyed during the weekend for fresh cues ahead of the weekly opening.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.